当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:3571.66亿  总市值:4382.71亿
流通股本:24.73亿   总股本:30.35亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金46,623,514,314.6428,213,614,195.4212,564,206,385.749,091,382,140.18
  收到的税费返还1,305,017,909.96902,942,139.84529,798,491.221,634,093,531.38
  收到其他与经营活动有关的现金1,000,579,027.91720,061,192.06466,971,301.731,027,087,659.72
  经营活动现金流入小计48,929,111,252.5129,836,617,527.3213,560,976,178.6551,752,563,331.28
  购买商品、接受劳务支付的现金17,677,190,839.2610,759,486,083.124,801,463,683.818,403,824,521.79
  支付给职工以及为职工支付的现金8,320,657,518.85,954,553,189.463,549,166,099.9210,450,935,927.56
  支付的各项税费4,230,139,351.172,522,179,774.481,217,418,205.333,755,189,879.64
  支付其他与经营活动有关的现金1,507,967,819.99901,256,092.18397,117,863.071,939,451,380.29
  经营活动现金流出小计31,735,955,529.2220,137,475,139.249,965,165,852.1234,549,401,709.28
  经营活动产生的现金流量净额17,193,155,723.299,699,142,388.083,595,810,326.5317,203,161,622
二、投资活动产生的现金流量:
  收回投资收到的现金22,992,351,078.1913,176,532,991.123,366,510,544.5121,007,291,673.48
  取得投资收益收到的现金193,592,476.72118,181,688.8129,116,209.77482,697,536.68
  处置固定资产、无形资产和其他长期资产收回的现金净额177,020,958.36115,771,107.0424,688,122.375,118,927.4
  处置子公司及其他营业单位收到的现金净额428,901,020.94398,053,880.94398,053,880.942,902,727,868.2
  投资活动现金流入小计23,791,865,534.2113,808,539,667.913,818,368,757.5224,467,836,005.76
  购建固定资产、无形资产和其他长期资产支付的现金5,081,805,986.922,961,579,116.411,194,798,903.265,538,150,829.94
  投资支付的现金32,602,049,821.5121,703,449,839.137,971,938,663.5520,874,795,084.7
  投资活动现金流出小计37,683,855,808.4324,665,028,955.549,166,737,566.8126,412,945,914.64
  投资活动产生的现金流量净额-13,891,990,274.22-10,856,489,287.63-5,348,368,809.29-1,945,109,908.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金---7,045,823,546.01
  取得借款收到的现金9,058,513,694.565,770,910,166.773,377,302,944.5114,091,218,928.81
  发行债券收到的现金6,944,451,728.646,944,451,728.64--
  筹资活动现金流入小计16,002,965,423.212,715,361,895.413,377,302,944.5121,137,042,474.82
  偿还债务支付的现金8,920,600,0005,620,300,0003,400,300,00010,528,620,797.52
  分配股利、利润或偿付利息支付的现金6,282,743,685.874,753,541,066.1516,953,610.044,992,100,926.54
  其中:子公司支付给少数股东的股利、利润14,310,800--23,518,290
  支付其他与筹资活动有关的现金3,281,137,454.833,240,831,304.1735,028,816.844,492,779,705.3
  筹资活动现金流出小计18,484,481,140.713,614,672,370.323,452,282,426.8820,013,501,429.36
  筹资活动产生的现金流量净额-2,481,515,717.5-899,310,474.91-74,979,482.371,123,541,045.46
四、汇率变动对现金及现金等价物的影响-749,382,157.27-445,588,979.92-198,774,624.87-370,473,427.27
五、现金及现金等价物净增加额70,267,574.3-2,502,246,354.38-2,026,312,59016,011,119,331.31
  加:期初现金及现金等价物余额29,455,830,548.9529,455,830,548.9529,455,830,548.9513,444,711,217.64
  期末现金及现金等价物余额29,526,098,123.2526,953,584,194.5727,429,517,958.9529,455,830,548.95
补充资料:
  净利润-11,126,333,943.9-19,333,065,892.26
  资产减值准备-68,368,895.87-541,555,966.37
  固定资产和投资性房地产折旧-1,758,977,935.91-3,164,557,339.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,758,977,935.91-3,164,557,339.38
  无形资产摊销-58,368,193.16-132,413,984.1
  长期待摊费用摊销-33,668,132.76-89,610,245.16
  处置固定资产、无形资产和其他长期资产的损失-914,869.48-58,067,020.13
  固定资产报废损失-1,843,753.65-7,094,067.73
  公允价值变动损失--684,234,468.06-137,097,911.32
  财务费用-548,528,885.02-1,073,373,133.94
  投资损失--227,724,271.36--8,588,017,064.9
  递延所得税--69,828,026.03--197,904,753.64
  其中:递延所得税资产减少--96,518,413.82--115,912,084.53
    递延所得税负债增加-26,690,387.79--81,992,669.11
  存货的减少--2,127,689,190.2--3,662,118,123.51
  经营性应收项目的减少--3,709,917,660.34--229,618,572.96
  经营性应付项目的增加-2,405,644,708.86-3,797,761,790.71
  其他-341,582,115.04-801,757,310.91
  现金的期末余额-26,953,584,194.57-29,455,830,548.95
  减:现金的期初余额-29,455,830,548.95-13,444,711,217.64
  现金及现金等价物的净增加额--2,502,246,354.38-16,011,119,331.31
公告日期2026-10-272026-08-042026-04-282026-03-24
审计意见(境内)标准无保留意见
TOP↑